MainBoardListed
Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited

Company website
Subscription runs from 30-07-2024 to 01-08-2024, with allotment expected on 02-08-2024.
Akums Drugs and Pharmaceuticals Limited is seeking ₹2,73,68,143 crore — a fresh issue of ₹1,00,37,708 crore plus OFS of ₹1,73,30,435 crore. Expect market interest to determine final listing performance.
Start Date30-07-2024
End Date01-08-2024
Listing Date06-08-2024
Allotment Date02-08-2024
Current Price₹725
GMP₹43 (6.33%)
Lot Size22 Shares
Subscription63.56 Times
Face Value₹2 per share
Listing atNSE, BSE
Issue Price₹646 - ₹679
Pre Issue₹14,73,56,280
Post Issue₹15,73,71,007
Issue Size₹2,73,68,143
(aggregating up to 1856.74 Cr)
Fresh Issue₹1,00,37,708
(aggregating up to 680.99 Cr)
Offer For Sale₹1,73,30,435
(aggregating up to 1175.75 Cr)
The Grey Market Premium (GMP) for Akums Drugs and Pharmaceuticals Limited is currently around ₹43 (6.33%). This indicates an estimated listing price of approximately ₹689 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
21 Nov 2025, 09:14
₹679
₹43
₹722 (6.33%)
01 Mar 2025, 08:31
₹679
₹43
₹722 (6.33%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Akums Drugs and Pharmaceuticals Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIMar-24Mar-23Mar-22
EPS
0.28
6.63
-17.65
ROE
0.11
13.52
-40.13
ROCE
3.37
24.60
-18.89
RONW
-0.57
13.23
-40.60
PRE IPO(PE)
0
0
0
POST IPO(PE)
0
0
0

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹552.52
49778.7
90.09
RETAIL
₹184.17
3922.58
21.30
HNIs 2+
₹92.09
2926.52
31.78
HNIs 10+
₹184.17
8735.31
47.43
EMPLOYEES
₹16.56
70.7
4.27
Total
₹1,029.51
65433.81
63.56

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
HNIs(10L +)
8,807
84,932
9.64
HNIs (2-10L)
4,403
1,35,305
30.73
RETAIL
1,23,292
21,04,030
17.07
Total
1,36,502
23,24,267
17.03
The IPO reservation for Akums Drugs and Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
QIB
53.67%
81,37,276
HNI
26.83%
40,68,637
RETAIL
17.89%
27,12,424
Employee
1.61%
2,43,902
TOTAL
100.00%
1,51,62,239

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
1
22
₹14,938
0
sHNI
14
308
₹2,09,132
0
bHNI
67
1,474
₹10,00,846
0
Below you can find the official contact details of Akums Drugs and Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 11 6904 1000
Address: 304, Mohan Place, LSC Saraswati Vihar, Delhi - 110 034

IPO Registrar

Name: Link Intime India Private Limited
Phone: +91-22-4918 6270
Akums Drugs and Pharmaceuticals Limited IPO Details — GMP: ₹43 (6.33%) | Grey Market IPO